Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Abstract

The protein-kinase family is the most frequently mutated gene family found in human cancer and faulty kinase enzymes are being investigated as promising targets for the design of antitumour therapies. We have sequenced the gene encoding the transmembrane protein tyrosine kinase ERBB2 (also known as HER2 or Neu) from 120 primary lung tumours and identified 4% that have mutations within the kinase domain; in the adenocarcinoma subtype of lung cancer, 10% of cases had mutations. ERBB2 inhibitors, which have so far proved to be ineffective in treating lung cancer, should now be clinically re-evaluated in the specific subset of patients with lung cancer whose tumours carry ERBB2 mutations.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer.
    Zhang S, Wang W, Xu C, Zhang Y, Cai X, Wang Q, Song Z, Li Z, Yu J, Zhong W, Wang Z, Liu J, Liu A, Li W, Zhan P, Liu H, Lv T, Miao L, Min L, Lin G, Huang L, Yuan J, Jiang Z, Pu X, Rao C, Lv D, Yu Z, Li X, Tang C, Zhou C, Zhang J, Guo H, Chu Q, Meng R, Liu X, Wu J, Zhou J, Zhu Z, Pan W, Dong X, Pang F, Wang K, Yao C, Lin G, Li S, Yang Z, Luo J, Jia H, Nie X, Wang L, Zhu Y, Hu X, Xie Y, Lin X, Cai J, Xia Y, Feng H, Wang L, Du Y, Yao W, Shi X, Niu X, Yuan D, Yao Y, Kang J, Zhang J, Zhang C, Gao W, Huang J, Zhang Y, Sun P, Wang H, Ye M, Wang D, Wang Z, Wan B, Lv D, Yu G, Shi L, Xia Y, Gao F, Zhang X, Xu T, Zhou W, Wang H, Liu Z, Yang N, Wu L, Wang Q, Wang G, Hong Z, Wang J, Fang M, Fang Y, Zhang Y, Song Y, Ma S, Fang W, Lu Y. Zhang S, et al. Thorac Cancer. 2023 Jan;14(1):91-104. doi: 10.1111/1759-7714.14743. Epub 2022 Nov 28. Thorac Cancer. 2023. PMID: 36444143 Free PMC article.
  • EGFR forms ligand-independent oligomers that are distinct from the active state.
    Byrne PO, Hristova K, Leahy DJ. Byrne PO, et al. J Biol Chem. 2020 Sep 18;295(38):13353-13362. doi: 10.1074/jbc.RA120.012852. Epub 2020 Jul 29. J Biol Chem. 2020. PMID: 32727847 Free PMC article.
  • Targeted therapy in NSCLC driven by HER2 insertions.
    Peters S, Zimmermann S. Peters S, et al. Transl Lung Cancer Res. 2014 Apr;3(2):84-8. doi: 10.3978/j.issn.2218-6751.2014.02.06. Transl Lung Cancer Res. 2014. PMID: 25806285 Free PMC article. Review.
  • Morphological and molecular characteristics of HER2 amplified urothelial bladder cancer.
    Tschui J, Vassella E, Bandi N, Baumgartner U, Genitsch V, Rotzer D, Seiler R, Thalmann GN, Fleischmann A. Tschui J, et al. Virchows Arch. 2015 Jun;466(6):703-10. doi: 10.1007/s00428-015-1729-4. Epub 2015 Mar 26. Virchows Arch. 2015. PMID: 25809292 Free PMC article.
  • A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma.
    Bekaii-Saab T, Williams N, Plass C, Calero MV, Eng C. Bekaii-Saab T, et al. BMC Cancer. 2006 Dec 6;6:278. doi: 10.1186/1471-2407-6-278. BMC Cancer. 2006. PMID: 17150109 Free PMC article.
See all "Cited by" articles

MeSH terms